Cell-based assays are an essential component to any life scientist’s tool kit. Whether in academic or industry-based research, the versatility of cell-based assays has allowed for them to be employed in a wide range of applications. These assays allow scientists to analyze complex cellular functions, to probe the relationship between cellular dysfunction and disease, to enable pathway-specific drug screenings, and to study the effects of gene-editing on cellular phenotype and viability. With such a vast array of uses, cell-based assays have become one of the single greatest drivers of laboratory consumables purchasing. The latest report from BioInformatics LLC – Interactive Market Intelligence: The Market for Cell-Based Assays – is now available on our market dashboard.
Since we last published on the cell-based assay market, global lab funding for cell-based assays as grown by 13%. Compared to 12% between FY14 and FY15, this indicates that the market for cell-based assays is steadily evolving. The 2016 Market for Cell-Based Assays report will help suppliers of instrumentation and consumables track the most vital trends. Furthermore, the Interactive Market Intelligence platform will allow you to view and manipulate the data in hundreds of different ways so that you can optimize the data to fit your needs. You will be able to compare companies like ATCC, BD Biosciences, Bio-Rad, CST, Corning, Lonza, Millipore Sigma, and Thermo Fisher—along with many others—and understand how they stack up in the market for cells, kits and consumables.
This Interactive Market Intelligence report is based on the responses of over 900 qualified scientists currently using cell-based assays in their research. Many scientists are increasingly working to improve the biological relevance of their assays so as to more effectively simulate human in vivo conditions. Others, especially those engaged in drug discovery, employ cellular viability assays to screen chemical candidates. This year, 67% of scientists utilizing cell-based assays employed viability assays. The report also looks at various detection techniques, such as the microplate reader, which remains a critical instrumentation platform of the cell-based assay market. For scientists intending to update their laboratory equipment, microplate readers are an intended purchase for 98% of scientists. Life science suppliers have responded to the market’s demand for affordability and flexibility with both single detection and multi-mode microplate readers, thereby accommodating the diversity of cell-based assays.
In the long-standing market that is supplying resources for cell-based assays, entrenched companies with household names compete with newer companies that, while not yet having brand recognition, are afforded greater flexibility by their smaller scale. In such a crowded field, brand recognition and company reputation become as important as product quality. With 15% of scientists likely to switch primary suppliers this year, a well-informed marketing campaign can be the difference between a hemorrhaging consumer base and an expanding one. Our 2016 report will allow you to understand customer satisfaction across the field, from which you can identify where your new customers will come from and what will engender loyalty among your current base. With all of the pertinent information gathered in The 2016 Market for Cell-Based Assays at your fingertips, you will be able to strengthen your brand, satisfying your customers, and capture market share.